Characteristic Features of Pharmaceutical Cluster Formation and Development
Abstract
Aim. This study aims to determine the characteristic features of cluster formation and development through the example of the pharmaceutical industry. Tasks. 1) To determine the nature of the concepts “cluster” and “pharmaceutical cluster”; 2) to identify the components of the structure of a pharmaceutical cluster; 3) to analyze the role of the government in the formation of a pharmaceutical cluster, substantiating its development with the examples of world practices. Methods are based on the analysis of scientific and analytical publications on the subject, which makes it possible to solve the above tasks and eventually achieve the set goal. Conclusion. Evidence-based policy of cluster support is an effective tool for enhancing the competitiveness of the industry on the global scale, increasing innovative potential and economic growth rate in the regions, and ensuring sustainability and economic independence in the context of import substitution and globalization.
Keywords
фармацевтический кластер,
государство и фармацевтический кластер,
межстрановой сравнительный анализ,
институциональные взаимосвязи,
импортозамещение и глобализация,
pharmaceutical cluster,
government and pharmaceutical cluster,
cross-country analysis,
institutional interconnections,
import substitution and globalization
About the Author
Nino A. Khazaliya
Graduate School of Management, St. Petersburg State University
Russian Federation
Russian Federation
References
1. Porter M. E. Location, Competition, and Economic Development: Local Clusters in a Global Economy // Economic Development Quarterly. 2000. Vol. 14, N 1. P. 15-34.
2. Schmitz H. On the clustering of small firms // IDS Bulletin. Vol. 23. 1992. P. 64-69.
3. Swann G. M. P., Prevezer M. A Comparison of the Dynamics of Industrial Clustering in Computing and Biotechnology // Research Policy. Vol. 25, Issue 7. 1996. P. 1139-1157.
4. Feser E. J. Old and New Theories of Industry Clusters // Steiner M. (ed.) Clusters and Regional Specialisation: On Geography, Technology and Networks. London: Pion Press. 1998. 279 p.
5. Elsner W. An industrial policy agenda 2000 and beyond: Experience, Theory and Policy // Elsner W., Groenewegen J. Industrial Policies After 2000. Springer Science & Business Media. 459 p.
6. Steiner M., Hartmann C. Learning with Clusters: A Case Study from Upper Styria // Steiner M. (ed.) Clusters and Regional Specialisation: On Geography, Technology and Networks. London: Pion Press, 1998. 279 p.
7. Egan T. Toronto Competence: An Assessment of Toronto’s Global Competitiveness // Toronto: Economic Development Office. 2000.
8. Parto S. Innovation and Economic Activity: An Institutional Analysis of the Role of Clusters in Industrializing Economies // Journal of economic issues. 2008. Vol. 42, N 4. P. 1005-1030.
9. Krugman P. Geography and Trade // London: MIT Press/ Leuven UP. 1991. 142 p.
10. Дугаржапов З. Б. Институциональные особенности как фактор социально-экономических различий регионов // Вестник Бурятского национального университета. 2013. № 2. С. 85-88.
11. Diagnostic Study Report on Pharmaceutical Clusters - Cuttack & Bhubaneswar: [Электронный ресурс]. Режим доступа: http://diodisha.nic.in/Doc/Cluster/cluster_pharma.pdf.
12. The Congress of the United States, Congressional Budget Office. Research and Development in the Pharmaceutical Industry // A CBO Studio. 2006: [Электронный ресурс]. Режим доступа: http://www.cbo.gov/ftpdocs/76xx/doc7615/10-02-DrugR-D.pdf.
13. National competitiveness team. Jordanian Pharmaceutical cluster / Ministry of Planning. 2000: [Электронный ресурс]. Режим доступа: http://www.competitiveness.gov.jo/files/Pharmaceutical%20Cluster.pdf.
Review
For citations:
Khazaliya N.A. Characteristic Features of Pharmaceutical Cluster Formation and Development. Economics and Management. 2016;(8):56-59. (In Russ.)
Views:
200
